drugset / Trial / NCT02119754

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

NCT02119754 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and meet all other entry criteria to be enrolled and receive PluroGel PN.

Timeline

Start
2013-10
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Plurogel PN Unknown — Topical